Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
An Openlabel, expanded acess protocol for Amifampridine Phosphate (3.4Diaminopyridine Phosphate) treatment in patients with LambertEaton Myasthenic Syndrome (LEMS), congenital myasthenic syndrome and downbeat nystagmus.
Shanina, Elena
(PI)
Neurology
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
2/24/16
→
2/23/18
Funding
Catalyst Pharmaceuticals, Inc ( Award # ):
$6,000.00
View all
View less